Detalhe da pesquisa
1.
Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction.
Acta Pharmacol Sin;
44(9): 1932-1934, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36944800